Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
- W. Symmans, F. Peintinger, L. Pusztai
- MedicineJournal of clinical oncology : official journal…
- 1 October 2007
TLDR
Breast carcinoma in men
- S. Giordano, D. Cohen, A. Buzdar, G. Perkins, G. Hortobagyi
- MedicineCancer
- 1 July 2004
TLDR
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
- K. Hess, K. Anderson, L. Pusztai
- MedicineJournal of clinical oncology : official journal…
- 10 September 2006
TLDR
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
- H. Kuerer, L. Newman, S. Singletary
- MedicineJournal of clinical oncology : official journal…
- 1 February 1999
TLDR
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health…
- J. Cuzick, M. Dowsett, J. Forbes
- MedicineJournal of clinical oncology : official journal…
- 10 November 2011
TLDR
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth…
- A. Buzdar, N. Ibrahim, G. Hortobagyi
- MedicineJournal of clinical oncology : official journal…
- 1 June 2005
TLDR
Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.
- J. Blum, S. Jones, T. Griffin
- MedicineJournal of clinical oncology : official journal…
- 1 February 1999
TLDR
...
...